U.S. markets open in 8 hours 53 minutes
  • S&P Futures

    4,419.50
    -2.00 (-0.05%)
     
  • Dow Futures

    34,908.00
    -35.00 (-0.10%)
     
  • Nasdaq Futures

    15,166.50
    -1.25 (-0.01%)
     
  • Russell 2000 Futures

    2,230.30
    -2.40 (-0.11%)
     
  • Crude Oil

    69.20
    +0.11 (+0.16%)
     
  • Gold

    1,802.30
    -6.60 (-0.36%)
     
  • Silver

    25.16
    -0.14 (-0.54%)
     
  • EUR/USD

    1.1826
    -0.0011 (-0.09%)
     
  • 10-Yr Bond

    1.2170
    0.0000 (0.00%)
     
  • Vix

    17.28
    -0.69 (-3.84%)
     
  • GBP/USD

    1.3920
    -0.0010 (-0.08%)
     
  • USD/JPY

    109.8410
    +0.0880 (+0.08%)
     
  • BTC-USD

    39,946.03
    +569.42 (+1.45%)
     
  • CMC Crypto 200

    986.78
    +10.89 (+1.12%)
     
  • FTSE 100

    7,120.43
    -3.43 (-0.05%)
     
  • Nikkei 225

    27,805.18
    +77.08 (+0.28%)
     

New Strong Sell Stocks for May 27th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:

Afya Limited AFYA is a medical education group. The Zacks Consensus Estimate for its current year earnings has been revised 3.9% downward over the last 30 days.

Broadstone Net Lease, Inc. BNL is an internally-managed REIT. The Zacks Consensus Estimate for its current year earnings has been revised 2.8% downward over the last 30 days.

Caladrius Biosciences, Inc. CLBS is an immunotherapy company. The Zacks Consensus Estimate for its current year earnings has been revised 11.3% downward over the last 30 days.

Ekso Bionics Holdings, Inc. EKSO is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The Zacks Consensus Estimate for its current year earnings has been revised 6.3% downward over the last 30 days.

Eli Lilly and Company LLY discovers, develops, manufactures, and markets human pharmaceuticals. The Zacks Consensus Estimate for its current year earnings has been revised 2.3% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Eli Lilly and Company (LLY) : Free Stock Analysis Report
 
Ekso Bionics Holdings, Inc. (EKSO) : Free Stock Analysis Report
 
Caladrius Biosciences, Inc. (CLBS) : Free Stock Analysis Report
 
Afya Limited (AFYA) : Free Stock Analysis Report
 
Broadstone Net Lease, Inc. (BNL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research